Literature DB >> 9793385

[Systemic side-effects of latanoprost in a child with aniridia and glaucoma].

F Schmidtborn1.   

Abstract

In a child with aniridia and glaucoma, a beta-receptor blocking drug was used in combination with Latanoprost. This was done because other combinations of antiglaucoma eyedrops had an insufficient pressure-reducing effect. It was very effective in reducing the pressure. However, there was a side effect: heavy sweat secretion over the entire body occurred 1-2 h after the application of Latanoprost drops. This side effect has not been described previously, and it indicates a systemic side effect of Latanoprost eyedrops. The systemic side effects of this substance are stronger then heretofore assumed, even in the case of proper local application. Therefore, one should be particularly careful in utilizing this substance, especially in children.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9793385     DOI: 10.1007/s003470050326

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN: 0941-293X            Impact factor:   1.059


  5 in total

Review 1.  Pediatric Glaucoma: Pharmacotherapeutic Options.

Authors:  Monica Samant; Anagha Medsinge; Ken K Nischal
Journal:  Paediatr Drugs       Date:  2016-06       Impact factor: 3.022

Review 2.  Drug-induced hyperhidrosis and hypohidrosis: incidence, prevention and management.

Authors:  William P Cheshire; Robert D Fealey
Journal:  Drug Saf       Date:  2008       Impact factor: 5.606

3.  Latanoprost in port wine stain related paediatric glaucoma.

Authors:  T Ong; A Chia; K K Nischal
Journal:  Br J Ophthalmol       Date:  2003-09       Impact factor: 4.638

Review 4.  Systemic side effects of eye drops: a pharmacokinetic perspective.

Authors:  Andre Farkouh; Peter Frigo; Martin Czejka
Journal:  Clin Ophthalmol       Date:  2016-12-07

5.  The Management of Uveitic Glaucoma in Children

Authors:  Dimitrios Kalogeropoulos; Christos Kalogeropoulos; Marilita M. Moschos; Velota Sung
Journal:  Turk J Ophthalmol       Date:  2019-10-24
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.